When did PTC THERAPEUTICS INC (PTCT) report earnings last quarter?
PTC THERAPEUTICS INC (PTCT) last reported earnings on 2/19/2026.
NASDAQ:PTCT • US69366J2006
Past quarterly earnings results for PTC THERAPEUTICS INC (PTCT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.67 | 0.04 | -4,466.01% | 22.33% | 213.2M | 282.2M | -24.45% | 0.01% |
| Q3 2025 | 0.20 | -1.40 | 114.33% | 114.39% | 211.007M | 188.96M | 11.67% | 7.23% |
| Q2 2025 | -0.83 | -1.08 | 23.33% | 34.65% | 178.875M | 174.38M | 2.58% | -4.19% |
| Q1 2025 | 10.04 | -0.22 | 4,742.99% | 936.67% | 1.176B | 171.61M | 585.33% | 459.73% |
| Q4 2024 | -2.15 | -0.67 | -221.32% | -795.83% | 213.172M | 237.09M | -10.09% | -30.58% |
| Q3 2024 | -1.39 | -1.47 | 5.49% | 21.02% | 196.786M | 176.11M | 11.74% | 0.11% |
| Q2 2024 | -1.27 | -1.07 | -18.68% | 52.26% | 186.704M | 189.03M | -1.23% | -12.68% |
| Q1 2024 | -1.20 | -1.27 | 5.18% | 36.17% | 210.118M | 173.1M | 21.39% | -4.66% |
| Q4 2023 | -0.24 | 0.51 | -147.48% | 87.30% | 307.056M | 327.72M | -6.31% | 83.43% |
| Q3 2023 | -1.76 | -1.19 | -47.41% | -15.03% | 196.576M | 214.4M | -8.31% | -9.45% |
| Q2 2023 | -2.66 | -1.27 | -109.52% | -24.88% | 213.808M | 211.13M | 1.27% | 29.19% |
| Q1 2023 | -1.88 | -1.32 | -41.94% | -5.62% | 220.382M | 204.49M | 7.77% | 48.21% |
| Q4 2022 | -1.89 | -1.62 | -16.38% | 6.90% | 167.4M | 192.92M | -13.23% | 1.33% |
| Q3 2022 | -1.53 | -1.27 | -20.74% | 19.05% | 217.1M | 190.64M | 13.88% | 56.52% |
| Q2 2022 | -2.13 | -1.36 | -56.73% | -26.79% | 165.5M | 165.33M | 0.10% | 41.82% |
| Q1 2022 | -1.78 | -1.54 | -15.81% | 2.73% | 148.7M | 150M | -0.87% | 26.12% |
| Q4 2021 | -2.03 | -1.68 | -20.96% | -87.96% | 165.2M | 153.85M | 7.38% | 38.94% |
| Q3 2021 | -1.89 | -1.52 | -24.74% | -83.50% | 138.7M | 122.85M | 12.90% | 17.15% |
| Q2 2021 | -1.68 | -1.85 | 9.39% | 35.88% | 116.7M | 112.71M | 3.54% | 55.19% |
| Q1 2021 | -1.83 | -1.54 | -18.59% | -1.10% | 117.9M | 100.78M | 16.99% | 72.62% |
| Q4 2020 | -1.08 | -0.95 | -13.15% | - | 118.9M | 113.58M | 4.68% | - |
| Q3 2020 | -1.03 | -0.06 | -1,674.08% | - | 118.4M | 114.45M | 3.45% | - |
| Q2 2020 | -2.62 | -1.33 | -97.71% | - | 75.2M | 84.434M | -10.94% | - |
| Q1 2020 | -1.81 | -1.35 | -33.60% | - | 68.3M | 81.664M | -16.36% | - |
Notes
PTC THERAPEUTICS INC (PTCT) last reported earnings on 2/19/2026.
PTC THERAPEUTICS INC (PTCT) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, PTC THERAPEUTICS INC (PTCT) has beaten EPS estimates in 3 out of 4 releases.